Statewide
Nebraska Medicine Division of Prehospital and Emergency Medical Services
Drugs and doses50
A–C Acetaminophen, Albuterol, Amiodarone, Aspirin, Atropine, Calcium Chloride, Calcium Gluconate7
Acetaminophen
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 325–1000 mg | PO | not captured | standing | pages 25, 87 |
| Mild to moderate pain | adult | 650–1000 mg | IV/IO | not captured | standing | pages 25, 87 |
| Mild to moderate pain | peds | 15 mg/kg | PO | not captured | standing | pages 25, 87 |
| Mild to moderate pain | peds | 15 mg/kg | IV/IO | not captured | standing | pages 25, 87 |
Albuterol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 2.5 mg | NEB | not captured | standing | pages 65, 111 |
| Asthma / bronchospasm | peds | 2.5 mg | NEB | not captured | standing | pages 65, 111 |
| Respiratory distress | adult | 2.5 mg | NEB | not captured | standing | pages 65, 111 |
| Respiratory distress | peds | 2.5 mg | NEB | not captured | standing | pages 65, 111 |
Amiodarone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Wide-complex tachycardia | adult | 150 mg | IV/IO | not captured | standing | pages 39, 171 |
| VF / pulseless VT | adult | 300 mg | IV/IO | not captured | standing | pages 31, 32, 91, 92, 171 |
| VF / pulseless VT | adult | 300 mg | IV/IO | not captured | standing | pages 31, 32, 91, 92, 171 |
| VF / pulseless VT | peds | 5 mg/kg | IV/IO | not captured | standing | pages 31, 32, 91, 92, 171 |
| VF / pulseless VT | peds | 5 mg/kg | IV/IO | not captured | standing | pages 31, 32, 91, 92, 171 |
Aspirin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 324 mg | PO | not captured | standing | pages 43, 172 |
Atropine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Bradycardia | adult | 1 mg | IV/IO | not captured | standing | pages 41, 99, 173 |
| Bradycardia | peds | 0.02 mg/kg | IV/IO | not captured | standing | pages 41, 99, 173 |
| Organophosphate poisoning | adult | 2 mg | IV/IO | not captured | standing | pages 151, 173 |
| Organophosphate poisoning | peds | 0.05 mg/kg | IV/IO | not captured | standing | pages 151, 173 |
| Organophosphate poisoning | peds | 0.05 mg/kg | IV/IO/IM | not captured | standing | page 151 |
Calcium Chloride
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Beta-blocker / calcium-channel-blocker overdose | adult | 1000 mg | IV/IO | not captured | standing | pages 109, 174 |
| Beta-blocker / calcium-channel-blocker overdose | peds | 20 mg/kg | IV/IO | not captured | standing | pages 109, 174 |
Calcium Gluconate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Beta-blocker / calcium-channel-blocker overdose | adult | 1 g | IV/IO | not captured | standing | pages 109, 131, 175 |
| Beta-blocker / calcium-channel-blocker overdose | peds | 20 mg/kg | IV/IO | not captured | standing | pages 109, 131, 175 |
| Hyperkalemia | adult | 1 g | IV/IO | not captured | standing | pages 31, 33, 125, 175 |
| Hyperkalemia | peds | 60–100 mg/kg | IV/IO | not captured | standing | pages 31, 33, 125, 175 |
D–F Dexamethasone, Dextrose, Diazepam, Diltiazem, Diphenhydramine, Dopamine, Droperidol, Epinephrine, Etomidate, Fentanyl10
Dexamethasone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 0.6 mg/kg | IV/IO | not captured | standing | pages 49, 101 |
| Allergic reaction | peds | 0.6 mg/kg | IV/IO | not captured | standing | pages 49, 101 |
| Respiratory distress | adult | 0.6 mg/kg | IV/IO | not captured | standing | pages 65, 111 |
| Respiratory distress | peds | 0.6 mg/kg | IV/IO | not captured | standing | pages 65, 111 |
Dextrose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 25 g | IV/IO | not captured | standing | page 176 |
| Hypoglycemia | peds | 0.5 g/kg | IV/IO | not captured | standing | page 176 |
Diazepam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Seizure | adult | 2 mg | IV/IO | not captured | standing | pages 67, 178 |
| Seizure | peds | 0.1 mg/kg | IV/IO | not captured | standing | pages 67, 178 |
| Seizure | peds | 0.2 mg/kg | PR | not captured | standing | page 178 |
Diltiazem
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Narrow-complex tachycardia | adult | 0.25 mg/kg | IV/IO | not captured | standing | pages 37, 179 |
Diphenhydramine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 25 mg | IV | not captured | standing | page 11 |
| Agitation | adult | 50 mg | IM | not captured | standing | page 11 |
| Allergic reaction | adult | 25–50 mg | IV/IO | not captured | standing | pages 49, 101 |
| Allergic reaction | peds | 1 mg/kg | IV/IO | not captured | standing | pages 49, 101 |
| Dystonic reaction | adult | 50 mg | IV/IO/IM | not captured | standing | pages 12, 71, 101 |
| Dystonic reaction | peds | 1 mg/kg | IV/IO/IM | not captured | standing | pages 12, 71, 101 |
Dopamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Bradycardia | adult | 5–20 mcg/kg | IV/IO | not captured | standing | pages 35, 36, 41, 42 |
| Bradycardia | peds | 5–20 mcg/kg | IV/IO | not captured | standing | pages 35, 36, 41, 42 |
| Hypotension / shock | adult | 5–20 mcg/kg | IV/IO | not captured | standing | pages 35, 36, 61, 62, 107, 108 |
| Hypotension / shock | peds | 5–20 mcg/kg | IV/IO | not captured | standing | pages 35, 36, 61, 62, 107, 108 |
Droperidol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 2.5–5 mg | IV | not captured | standing | page 11 |
| Agitation | adult | 5–10 mg | IM | not captured | standing | page 11 |
Epinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 0.3–0.5 mg | IM | not captured | standing | pages 49, 101, 183 |
| Anaphylaxis | peds | 0.15 mg | IM | not captured | standing | pages 49, 101, 183 |
| Asthma / bronchospasm | adult | 0.3 mg | IM | not captured | standing | page 183 |
| Asthma / bronchospasm | peds | 0.15 mg | IM | not captured | standing | page 183 |
| Bradycardia | adult | 2–10 mcg | IV/IO | not captured | standing | pages 41, 42, 99, 100, 185 |
| Cardiac arrest | adult | 1 mg | IV/IO | not captured | standing | pages 31, 32, 33, 34, 91, 92, 93, 94, 184 |
| Cardiac arrest | peds | 0.01 mg/kg | IV/IO | not captured | standing | pages 31, 32, 33, 34, 91, 92, 93, 94, 184 |
Etomidate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| RSI induction | adult | 0.3 mg/kg | IV/IO | not captured | standing | pages 21, 83, 186 |
| RSI induction | peds | 0.3 mg/kg | IV/IO | not captured | standing | pages 21, 83, 186 |
Fentanyl
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 1 mcg/kg | IV/IO/IM/IN | not captured | standing | pages 25, 87 |
| Mild to moderate pain | peds | 1 mcg/kg | IV/IO/IM/IN | not captured | standing | pages 25, 87 |
| Post-intubation sedation | adult | 1 mcg/kg | IV/IO | not captured | standing | pages 23, 85 |
| Post-intubation sedation | peds | 1 mcg/kg | IV/IO | not captured | standing | pages 23, 85 |
G–L Glucagon, Haloperidol, Hydromorphone, Hydroxocobalamin, Ibuprofen, Ipratropium, Ketamine, Ketorolac, Labetalol, Lidocaine, Lorazepam11
Glucagon
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Beta-blocker / calcium-channel-blocker overdose | adult | 2 mg | IV/IO | not captured | standing | pages 109, 188 |
| Beta-blocker / calcium-channel-blocker overdose | peds | 0.1 mg/kg | IV/IO | not captured | standing | pages 109, 188 |
| Hypoglycemia | adult | 1 mg | IM/SQ | not captured | standing | pages 105, 188 |
| Hypoglycemia | peds | 0.1 mg/kg | IM/SQ | not captured | standing | pages 105, 188 |
Haloperidol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 2.5–5 mg | IV | not captured | standing | page 11 |
| Agitation | adult | 5–10 mg | IM | not captured | standing | page 11 |
Hydromorphone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.5–1 mg | IV/IO | not captured | standing | pages 23, 189 |
| Other | peds | 0.01 mg/kg | IV/IO | not captured | standing | pages 23, 189 |
| Mild to moderate pain | adult | 0.5–1 mg | IV/IO/IM/IN | not captured | standing | page 25 |
Hydroxocobalamin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cyanide poisoning | adult | 5 g | IV/IO | not captured | standing | pages 149, 190 |
| Cyanide poisoning | peds | 70 mg/kg | IV/IO | not captured | standing | pages 149, 190 |
Ibuprofen
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 400–800 mg | PO | not captured | standing | pages 25, 87 |
| Mild to moderate pain | peds | 10 mg/kg | PO | not captured | standing | pages 25, 87 |
Ipratropium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 0.5 mg | NEB | not captured | standing | pages 65, 111 |
| Asthma / bronchospasm | peds | 0.5 mg | NEB | not captured | standing | pages 65, 111 |
| Respiratory distress | adult | 0.5 mg | NEB | not captured | standing | pages 65, 111 |
| Respiratory distress | peds | 0.5 mg | NEB | not captured | standing | pages 65, 111 |
Ketamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 3–5 mg/kg | IM | not captured | standing | pages 11, 57 |
| Mild to moderate pain | adult | 0.1–0.2 mg/kg | IV/IO/IM | not captured | standing | pages 25, 87 |
| Mild to moderate pain | peds | 0.1–0.2 mg/kg | IV/IO/IM | not captured | standing | pages 25, 87 |
| Post-intubation sedation | adult | 0.5 mg/kg | IV/IO | not captured | standing | pages 23, 85 |
| Post-intubation sedation | peds | 0.5 mg/kg | IV/IO | not captured | standing | pages 23, 85 |
| Procedural sedation | adult | 1 mg/kg | IV/IO | not captured | standing | pages 37, 39, 97 |
| Procedural sedation | peds | 1 mg/kg | IV/IO | not captured | standing | pages 37, 39, 97 |
| RSI induction | adult | 3 mg/kg | IV/IO | not captured | standing | pages 21, 83 |
| RSI induction | peds | 2–3 mg/kg | IV/IO | not captured | standing | pages 21, 83 |
Ketorolac
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 15 mg | IV/IO | not captured | standing | pages 25, 87 |
| Mild to moderate pain | adult | 30 mg | IM | not captured | standing | pages 25, 87 |
Labetalol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 10–20 mg | IV | not captured | standing | pages 53, 195 |
Lidocaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 40 mg | IO | not captured | standing | page 196 |
| Other | peds | 0.5 mg/kg | IO | not captured | standing | page 196 |
| VF / pulseless VT | adult | 1.5 mg/kg | IV/IO | not captured | standing | pages 31, 32, 91, 92, 196 |
| VF / pulseless VT | adult | 1.5 mg/kg | IV/IO | not captured | standing | pages 31, 32, 91, 92, 196 |
| VF / pulseless VT | peds | 1 mg/kg | IV/IO | not captured | standing | pages 31, 32, 91, 92, 196 |
| VF / pulseless VT | peds | 1 mg/kg | IV/IO | not captured | standing | pages 31, 32, 91, 92, 196 |
Lorazepam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 1–2 mg | IV/IO | not captured | standing | page 11 |
| Agitation | adult | 2 mg | IV/IO | not captured | standing | page 11 |
| Other | adult | 0.5–1 mg | IV/IO/IN | not captured | standing | page 45 |
| Seizure | adult | 2 mg | IV/IO | not captured | standing | pages 67, 113, 197 |
| Seizure | peds | 0.1 mg/kg | IV/IO | not captured | standing | pages 67, 113, 197 |
M–O Magnesium Sulfate, Methylprednisolone, Metoclopramide, Metoprolol, Midazolam, Morphine, Naloxone, Nitroglycerin, Norepinephrine, Ondansetron, Oral Glucose11
Magnesium Sulfate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 2 g | IV/IO | not captured | standing | pages 65, 111 |
| Asthma / bronchospasm | peds | 40 mg/kg | IV/IO | not captured | standing | pages 65, 111 |
| VF / pulseless VT | adult | 2 g | IV/IO | not captured | standing | pages 31, 39, 91 |
| VF / pulseless VT | peds | 40 mg/kg | IV/IO | not captured | standing | pages 31, 39, 91 |
Methylprednisolone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 125 mg | IV/IO | not captured | standing | pages 49, 101 |
| Allergic reaction | peds | 1 mg/kg | IV/IO | not captured | standing | pages 49, 101 |
| Respiratory distress | adult | 125 mg | IV/IO | not captured | standing | pages 65, 111 |
| Respiratory distress | peds | 1 mg/kg | IV/IO | not captured | standing | pages 65, 111 |
Metoclopramide
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 10 mg | IV/IM | not captured | standing | pages 71, 200 |
| Nausea / vomiting | peds | 0.1–0.2 mg/kg | IV/IM | not captured | standing | pages 71, 200 |
Metoprolol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Narrow-complex tachycardia | adult | 2.5–5 mg | IV/IO | not captured | standing | pages 37, 201 |
Midazolam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 2 mg | IV/IO | not captured | standing | page 11 |
| Agitation | adult | 5 mg | IM | not captured | standing | page 11 |
| Other | adult | 1–2 mg | IV/IO/IN | not captured | standing | page 202 |
| Other | adult | 5–10 mg | IV/IO/IN | not captured | standing | page 202 |
| Other | peds | 0.05 mg/kg | IV/IO/IN | not captured | standing | page 202 |
| Post-intubation sedation | adult | 0.05 mg/kg | IV/IO/IM/IN | not captured | standing | pages 23, 85, 202 |
| Post-intubation sedation | peds | 0.05 mg/kg | IV/IO/IM/IN | not captured | standing | pages 23, 85, 202 |
| Procedural sedation | adult | 2 mg | IV/IO/IN | not captured | standing | page 202 |
| Procedural sedation | adult | 2 mg | IV/IO/IM/IN | not captured | standing | pages 37, 39, 97, 202 |
| Procedural sedation | peds | 0.1–0.2 mg/kg | IV/IO/IM/IN | not captured | standing | pages 37, 39, 97, 202 |
| Seizure | adult | 2 mg | IV/IO/IM/IN | not captured | standing | pages 29, 67, 113, 202 |
| Seizure | peds | 0.1–0.2 mg/kg | IV/IO/IM/IN | not captured | standing | pages 29, 67, 113, 202 |
Morphine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 0.1 mg/kg | IV/IO/IM | not captured | standing | pages 25, 87 |
| Mild to moderate pain | peds | 0.05 mg/kg | IV/IO/IM | not captured | standing | pages 25, 87 |
| Post-intubation sedation | adult | 0.1 mg/kg | IV/IO | not captured | standing | pages 23, 85 |
| Post-intubation sedation | peds | 0.1 mg/kg | IV/IO | not captured | standing | pages 23, 85 |
Naloxone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Opioid overdose | adult | 0.4–4 mg | IM/IN | not captured | standing | pages 25, 63, 109 |
| Opioid overdose | adult | 0.4–4 mg | IV/IO | not captured | standing | pages 25, 63, 109 |
| Opioid overdose | peds | 0.1 mg/kg | IM/IN | not captured | standing | pages 25, 63, 109 |
| Opioid overdose | peds | 0.1 mg/kg | IV/IO | not captured | standing | pages 25, 63, 109 |
Nitroglycerin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 0.4 mg | SL | not captured | standing | pages 43, 205 |
| CHF / pulmonary edema | adult | 0.4 mg | SL | not captured | standing | pages 45, 205 |
| Other | adult | 0.4 mg | SL | not captured | standing | pages 59, 205 |
Norepinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Bradycardia | adult | 4–30 mcg | IV/IO | not captured | standing | pages 35, 36, 41, 42 |
| Bradycardia | peds | 0.05–0.1 mcg/kg | IV/IO | not captured | standing | pages 35, 36, 41, 42 |
| Hypotension / shock | adult | 4–30 mcg | IV/IO | not captured | standing | pages 35, 36, 61, 62, 107, 108 |
| Hypotension / shock | peds | 0.05–0.1 mcg/kg | IV/IO | not captured | standing | pages 35, 36, 61, 62, 107, 108 |
Ondansetron
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 4 mg | IV/IO/IM/PO | not captured | standing | pages 71, 207 |
| Nausea / vomiting | peds | 0.15 mg/kg | IV/IO/IM/PO | not captured | standing | pages 71, 207 |
Oral Glucose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 15–31 g | PO | not captured | standing | pages 55, 177 |
| Hypoglycemia | peds | 7.5–15.5 g | PO | not captured | standing | pages 55, 177 |
P–R Pralidoxime, Prochlorperazine, Promethazine, Proparacaine, Racemic Epinephrine, Rocuronium6
Pralidoxime
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nerve agent exposure | adult | 600 mg | IM | not captured | standing | pages 151, 182 |
| Organophosphate poisoning | adult | 600 mg | IM | not captured | standing | pages 151, 182 |
Prochlorperazine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 5–10 mg | IV/IM | not captured | standing | pages 71, 209 |
Promethazine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 12.5 mg | IV/IO/IM/PO | not captured | standing | pages 71, 115, 210 |
| Nausea / vomiting | peds | 0.25–1 mg/kg | IV/IO/IM/PO | not captured | standing | pages 71, 115, 210 |
Proparacaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 1–2 drop | OPH | not captured | standing | pages 127, 211 |
| Mild to moderate pain | peds | 1–2 drop | OPH | not captured | standing | pages 127, 211 |
Racemic Epinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Croup | adult | 0.5 mg | NEB | not captured | standing | pages 111, 212 |
| Stridor | adult | 0.5 mg | NEB | not captured | standing | pages 111, 212 |
| Stridor | peds | 0.5 mg | NEB | not captured | standing | pages 111, 212 |
Rocuronium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1 mg/kg | IV/IO | not captured | standing | pages 23, 85 |
| Other | peds | 1 mg/kg | IV/IO | not captured | standing | pages 23, 85 |
| RSI induction | adult | 1 mg/kg | IV/IO | not captured | standing | pages 21, 83 |
| RSI induction | peds | 1 mg/kg | IV/IO | not captured | standing | pages 21, 83 |
S–Z Sodium Bicarbonate, Succinylcholine, Tetracaine, Tranexamic Acid, Vecuronium5
Sodium Bicarbonate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Crush injury | adult | 100 mEq | IV/IO | not captured | standing | page 125 |
| Crush injury | peds | 1 mEq/kg | IV/IO | not captured | standing | page 125 |
| Hyperkalemia | adult | 50 mEq | IV/IO | not captured | standing | pages 31, 93 |
| Hyperkalemia | peds | 1 mEq/kg | IV/IO | not captured | standing | pages 31, 93 |
| Other | adult | 100 mEq | IV/IO | not captured | standing | page 11 |
| Tricyclic overdose | adult | 100 mEq | IV/IO | not captured | standing | pages 63, 109, 214 |
| Tricyclic overdose | peds | 1 mEq/kg | IV/IO | not captured | standing | pages 63, 109, 214 |
Succinylcholine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| RSI induction | adult | 2 mg/kg | IV/IO | not captured | standing | pages 21, 83, 215 |
| RSI induction | peds | 2 mg/kg | IV/IO | not captured | standing | pages 21, 83, 215 |
Tetracaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 2 drop | OPH | not captured | standing | page 127 |
| Mild to moderate pain | peds | 2 drop | OPH | not captured | standing | page 127 |
Tranexamic Acid
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Trauma / hemorrhage | adult | 1 g | IV | not captured | standing | pages 117, 216 |
Vecuronium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.1 mg/kg | IV/IO | not captured | standing | pages 23, 85 |
| Other | peds | 0.1 mg/kg | IV/IO | not captured | standing | pages 23, 85 |
| RSI induction | adult | 0.1 mg/kg | IV/IO | not captured | standing | pages 21, 83 |
| RSI induction | peds | 0.1 mg/kg | IV/IO | not captured | standing | pages 21, 83 |
Cite this
Nebraska Medicine Division of Prehospital and Emergency Medical Services, United States EMS Protocol Census. 172 dose entries, effective 2026-05-01.
https://protoquiz.com/census/agencies/nebraska-board-of-emergency-medical-services/
The census is free and not for sale. Only public agencies are named.